Sign in

Peter van Galen

@vangalenlab.bsky.social
765 followers 221 following 49 posts

We study how blood ages & how to improve leukemia treatment, using cell biology + bioinformatics — @mgbresearch @harvardmed @broadinstitute — vangalenlab.org

PostsRepliesMedia
Reposted by Peter van Galen
Sandra McAllister, PhD @sandramcallister.bsky.social · 15/12/2025
🎀 Age influences breast cancer cell and molecular features 🎀 Congrats to our international team for the work featured in the December @nataging.nature.com issue! @vangalenlab.bsky.social @mgbresearch.bsky.social @harvardmed.bsky.social
041
Peter van Galen @vangalenlab.bsky.social · 15/12/2025
🟣🟣🟣 Check out this straightforward method of improving human hematopoietic stem cell expansion by inhibiting ferroptosis 🟣🟣🟣 thanks for including me @bloodgenes.bsky.social #hemesky 🧬🔬🧪
041
Peter van Galen @vangalenlab.bsky.social · 06/11/2025
Exciting to see our latest story out in print — with @sandramcallister.bsky.social — on how breast cancer differs between younger and older patients, leading the way to tailored management to improve outcomes 💻🔬🧬🧪
050
Reposted by Peter van Galen
Peter van Galen @vangalenlab.bsky.social · 28/09/2025
Congratulations! * Rapid epigenomic classification of acute leukemia* — the most innovative and impactful application of long-read sequencing and machine learning I know. Happy to be included!! #hemesky 🩸🧬💻🔬
061
Peter van Galen @vangalenlab.bsky.social · 28/09/2025
Congratulations! * Rapid epigenomic classification of acute leukemia* — the most innovative and impactful application of long-read sequencing and machine learning I know. Happy to be included!! #hemesky 🩸🧬💻🔬
061
Peter van Galen @vangalenlab.bsky.social · 07/09/2025
This new way of looking at cellular diversity in single-cell sequencing is transformative imo, which is why we've taken a similar approach to study aging blood stem cells. Congratulations @dkotliar.bsky.social and @soumya-boston.bsky.social! 🩸🧪🧬 #hemesky
071
Peter van Galen @vangalenlab.bsky.social · 06/09/2025
These findings provide new insight into blood aging at the source, and raise the possibility of targeting inflammatory HSCs to "rejuvenate" blood production in aging 🧪 Thanks Ksenia Safina and collaborators @trowbridgelab.bsky.social @bloodgenes.bsky.social Read more at doi.org/10.1101/2025... 5/5🏁
061
Peter van Galen @vangalenlab.bsky.social · 06/09/2025
We discovered a type of stem cells that expand with age and is dominated by a program of inflammation and quiescence (GEP:1 below), which could leave the blood system less able to renew itself 📊 4/5
140
Peter van Galen @vangalenlab.bsky.social · 06/09/2025
There is no clear agreement on the effects of aging on HSCs, and how different types of HSCs play into this. So we pulled seven datasets together and re-analyzed them using new bioinformatic methods, revealing a clearer picture 💻 3/5
150
Peter van Galen @vangalenlab.bsky.social · 06/09/2025
Aging of blood system leads to health problems such as weakened immunity and a higher risk of anemia. Many of these changes can be traced back to HSCs, which reside in the bone marrow and renew all blood cells 🔬 2/5
140
Peter van Galen @vangalenlab.bsky.social · 06/09/2025
Excited to share our latest work on blood aging! To find out why the blood system changes as people age, we started at the source: hematopoietic stem cells (HSCs) #hemesky 🩸🧬 doi.org/10.1101/2025... 🧵 1/5
15711
Peter van Galen @vangalenlab.bsky.social · 06/09/2025
There is no clear agreement on the effects of aging on HSCs, and how different types of HSCs play into this. So we pulled seven datasets together and re-analyzed them using new bioinformatic methods, revealing a clearer picture 3/5
000
Peter van Galen @vangalenlab.bsky.social · 06/09/2025
Aging of blood system leads to health problems such as weakened immunity and a higher risk of anemia. Many of these changes can be traced back to HSCs, which reside in the bone marrow and renew all blood cells 2/5
100
Peter van Galen @vangalenlab.bsky.social · 15/08/2025
New insights into the Unfolded Protein Response in hematopoietic stem cells in @bloodjournal.bsky.social this week + commentary from @basitsalik.bsky.social and me🩸🐁 #hemesky doi.org/10.1182/bloo...
doi.org
The PERKs of ER homeostasis for hematopoietic stem cells
In this issue of Blood, Zheng et al1 show that the unfolded protein response (UPR) sensor PERK (protein kinase R-like endoplasmic reticulum kinase) is disp
094
Peter van Galen @vangalenlab.bsky.social · 15/08/2025
Online today! *Aging, Immune Fitness and Cancer* 🔬 Learn the latest about the intersection between these processes in @natrevcancer.nature.com 🧬 Great to work with @sandramcallister.bsky.social lab again 😁 doi.org/10.1038/s415...
0167
Peter van Galen @vangalenlab.bsky.social · 05/08/2025
This may be my favorite paper of the year so far: integrating single-cell leukemia datasets to reveal how differentiation and mutations interact to drive disease, along with a tool that speeds up bone marrow cell annotation from ~4 weeks to ~4 hours..! aacrjournals.org/bloodcancerd... 🔬🩸🧬 #hemesky
061
Peter van Galen @vangalenlab.bsky.social · 05/08/2025
Noted!
010
Peter van Galen @vangalenlab.bsky.social · 04/08/2025
Whenever the team @posit.co brings out a new feature, it’s exactly how I wished it would be. AI integration done right 🧠 positron.posit.co/assistant @anthropic.com
020
Reposted by Peter van Galen
Vikram Paralkar @paralkarlab.bsky.social · 02/08/2025
📣 New preprint 📣 We present a detailed map of nascent and mature ribosomal RNAs in mouse hematopoiesis and AML (including absolute rRNA molecule numbers), and outline principles of rDNA regulation. Work by Eleanor Sams (@eleanor44.bsky.social) & Victoria Feist (@victoriafeist.bsky.social). (1/x)
biorxiv.org
Dynamics of Ribosomal RNA Transcription and Abundance in Normal and Leukemic Hematopoiesis
Transcription of ribosomal RNAs (rRNAs) from rDNA repeats is the first step of ribosome biogenesis, accounting for a major portion of all cellular transcription. Often regarded as a housekeeping proce...
24114
Peter van Galen @vangalenlab.bsky.social · 02/08/2025
Had a great time catching up with friends and learning new science at FASEB Hematologic Malignancies! #hemesky @faseborg.bsky.social #HEMSRC
0123
Reposted by Peter van Galen
Vikram Paralkar @paralkarlab.bsky.social · 30/07/2025
At the FASEB Heme Malignancies meeting with old friends and new - Pam Sung, Peter Van Galen (@vangalenlab.bsky.social), Julia Maxson (@juliamaxson.bsky.social), Johnathon Shafer. Trying out ales at the @treehousebrewing.bsky.social! #HEMSRC
1122
Peter van Galen @vangalenlab.bsky.social · 22/02/2025
#positron is rapidly replacing programs and websites I used with a customizable multilingual coding environment for data science (local+cluster+virtual machines) #bash #rstats #python @posit.co
0211
Reposted by Peter van Galen
Ann Mullally @mullallylab.bsky.social · 10/01/2025
Delighted to share our #hematology review article on mutant calreticulin in #MPN Congrats to co-authors Drs. Mifra Faiz, Merle Riedemann & Jonas Jutzi. We hope it’s a useful resource, link below! @stanforddeptmed.bsky.social link.springer.com/article/10.1...
link.springer.com
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications - Current Hematologic Malignancy Reports
Purpose of Review More than a decade following the discovery of Calreticulin (CALR) mutations as drivers of myeloproliferative neoplasms (MPN), advances in the understanding of CALR-mutant MPN continu...
0247
Peter van Galen @vangalenlab.bsky.social · 11/01/2025
Erasmus MC Hematology Lecture speaker lineup never fails to impress! #hemesky 🧪🩸 mcusercontent.com/71bcc0f3bb8a...
02512
Peter van Galen @vangalenlab.bsky.social · 04/01/2025
Just a reminder of what is easily in my top 5 of favorite papers from 2023 www.cell.com/iscience/ful... @bailee-kain.bsky.social @thekinglab.bsky.social
091
Peter van Galen @vangalenlab.bsky.social · 01/01/2025
Congrats! Look forward to using it
110
Peter van Galen @vangalenlab.bsky.social · 23/12/2024
Our latest work is now available to read on bioRxiv! Very proud of this and its potential implications for patients with acute myeloid leukemia 🩸 🧪 🔬💊 **eIF4A-mediated translation initiation as an AML cell vulnerability that can be co-targeted with BCL-2 inhibition** www.biorxiv.org/content/10.1...
34214
Peter van Galen @vangalenlab.bsky.social · 22/12/2024
Boston’s North End ❄️
0170
Peter van Galen @vangalenlab.bsky.social · 16/12/2024
I2 is likely the cell barcode. This is a common sequencing setup for 10x scATAC: * Read1: 50 (genomic DNA) * P7-i7: 8 (library index) * P5-i5: 24 (spacer [8] + cell barcode [16]) * Read2: 50 (genomic DNA)
100
Peter van Galen @vangalenlab.bsky.social · 16/12/2024
Our new review “Insights into Leukemia from Single-Cell Genomics” is out! Great work by Nurefsan Sariipek @nursariipek.bsky.social 📝 www.annualreviews.org/content/jour... #hemesky 🩸🧬
0186
Peter van Galen @vangalenlab.bsky.social · 05/12/2024
Office plants are watered, almost ready to hit the road #ASH24 🩸🧬 #HemeSky
1170
Peter van Galen @vangalenlab.bsky.social · 04/12/2024
www.exphem.org/article/S030...
000
Peter van Galen @vangalenlab.bsky.social · 04/12/2024
...setting a transcript threshold that seems appropriate for blood progenitors will eliminate many T cell populations. This is illustrated in our MAESTER paper supplement pubmed.ncbi.nlm.nih.gov/35210612/ Thanks @sandramcallister.bsky.social for sending this along 3/3 #HemeSky 🩸 #GeneSky 🧬
011
Peter van Galen @vangalenlab.bsky.social · 04/12/2024
Fundamentally, I would not recommend any universal QC pipeline across tissues and technologies. Datasets should be thoroughly evaluated by an expert with biological and computational expertise with a defined question. Simple example: cell types can have vastly different numbers of transcripts 👇🏻 2/3
120
Peter van Galen @vangalenlab.bsky.social · 04/12/2024
Interesting BMC Genomics paper filters "nucleus-free" low-quality cells using the number of intronic reads. MALAT1 expression may provide a shortcut, but I would be wary of filtering out meaningful data 1/3 🩸🧬 @tmontsay.bsky.social @annaesteveco.bsky.social www.ncbi.nlm.nih.gov/pubmed/39574...
170
Peter van Galen @vangalenlab.bsky.social · 04/12/2024
For example, setting a transcript threshold that seems appropriate for blood cell progenitors will eliminate many T cell populations. This is illustrated in this figure from our MAESTER paper supplement pubmed.ncbi.nlm.nih.gov/35210612/ Thanks @sandramcallister.bsky.social for sending this along 3/3
000
Peter van Galen @vangalenlab.bsky.social · 04/12/2024
Fundamentally, I would not recommend any universal QC pipeline across tissues and technologies. Datasets should be thoroughly evaluated by an expert with biological and computational expertise with a defined question. For one, cell types can have vastly different numbers of transcripts: 2/3
100
Peter van Galen @vangalenlab.bsky.social · 28/11/2024
On Thanksgiving day, what is the effect of frequent blood donations? Donors may have a higher prevalence of EPO-responsive clonal hematopoiesis, but there is no increased risk for malignant clones, underscoring safety of repetitive blood donations. www.medrxiv.org/content/10.1... 🩸🧪 #hemesky
1112
Peter van Galen @vangalenlab.bsky.social · 21/11/2024
This may be just what we need for our current question. Thanks! 🩸🧪
010
Reposted by Peter van Galen
Fabian Theis @fabiantheis.bsky.social · 20/11/2024
1/ 🧬 Single-cell genomics reveals biological variations beyond cell types. Unveiling these in separate latent dim’s is known as disentanglement. Led by @AmirAliMoinfar, we develop DRVI to learn nonlinear, disentangled & interpretable latent spaces. biorxiv.org/content/10.1101/2024.11.06.622266v1
313737
Peter van Galen @vangalenlab.bsky.social · 18/11/2024
Bad use case 🫠 (and reminder to carefully check everything ChatGPT generates)
020
Reposted by Peter van Galen
Kellie Machlus @kmachlus.bsky.social · 17/11/2024
Finally- the starter pack we have all been waiting for is here … Hematopoiesis 🎉❤️🩸🦴 So excited to have reached a critical mass of this community on here. 🙌🏻 Let me know if you want to be added!! go.bsky.app/KWdX5w7
398129
Peter van Galen @vangalenlab.bsky.social · 16/11/2024
Not many papers change the way I think about AML, but this exceptional work shows how cell states and genetics intertwine to mediate venetoclax resistance, unifying previous studies by identifying RAS-mutated LSCs that are primed to produce myeloid cells #hemesky 🩸🧪 www.nature.com/articles/s41...
0172
Peter van Galen @vangalenlab.bsky.social · 15/11/2024
Ok let’s give social media another try. I’ll share advances in blood/cancer/aging/bioinformatics research and pictures of my daily commute along Boston’s Esplanade like this one
1111
Peter van Galen @vangalenlab.bsky.social · 24/02/2024
Python ≠ my forte, but with the help of ChatGPT I created this nice little script to count files stored in Google Cloud Storage (GCS) buckets, categorized by their storage class (e.g., STANDARD, NEARLINE, COLDLINE, ARCHIVE). I hope it helps someone like it does me! 🐍 github.com/petervangale...
github.com
GitHub - petervangalen/count_storage_classes: Count the number of files in Google Cloud Storage (GCS) buckets categorized by their storage class
Count the number of files in Google Cloud Storage (GCS) buckets categorized by their storage class - petervangalen/count_storage_classes
030
Reposted by Peter van Galen
ernstlaboratory.bsky.social @ernstlaboratory.bsky.social · 23/02/2024
Special seminars! @bloodsky.bsky.social www.iseh.org/page/isehweb...
021
Peter van Galen @vangalenlab.bsky.social · 12/02/2024
Briefly went on X to look something up and on top of my feed was a video making fun of someone’s medical condition. Such a relief to be here 😇
020
Peter van Galen @vangalenlab.bsky.social · 10/02/2024
We started the ISEH Twitter account back in the day 👶🏼 I’ll check
000
Peter van Galen @vangalenlab.bsky.social · 08/02/2024
👏🏻 read this if you want to know the absolute cutting edge of single-cell RNA-seq to study hierarchical tissue renewal dynamics
000
Peter van Galen @vangalenlab.bsky.social · 06/02/2024
Oh nice! Posted to our lab Slack :)
000